Coverart for item
The Resource Bad blood : secrets and lies in a Silicon Valley startup, John Carreyrou

Bad blood : secrets and lies in a Silicon Valley startup, John Carreyrou

Label
Bad blood : secrets and lies in a Silicon Valley startup
Title
Bad blood
Title remainder
secrets and lies in a Silicon Valley startup
Statement of responsibility
John Carreyrou
Creator
Author
Subject
Language
eng
Summary
  • "The full inside story of the breathtaking rise and shocking collapse of a multibillion-dollar startup, by the prize-winning journalist who first broke the story and pursued it to the end in the face of pressure and threats from the CEO and her lawyers. In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: The technology didn't work. For years, Holmes had been misleading investors, FDA officials, and her own employees. When Carreyrou, working at The Wall Street Journal, got a tip from a former Theranos employee and started asking questions, both Carreyrou and the Journal were threatened with lawsuits. Undaunted, the newspaper ran the first of dozens of Theranos articles in late 2015. By early 2017, the company's value was zero and Holmes faced potential legal action from the government and her investors. Here is the riveting story of the biggest corporate fraud since Enron, a disturbing cautionary tale set amid the bold promises and gold-rush frenzy of Silicon Valley"--
  • "The full inside story of the breathtaking rise and shocking collapse of Theranos--the Enron of Silicon Valley--by the prize-winning journalist who first broke the story and pursued it to the end in the face of pressure and threats from the CEO and her lawyers. In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup "unicorn" promised to revolutionize the medical industry with a machine that would make blood tests significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in an early fundraising round that valued the company at $9 billion, putting Holmes's worth at an estimated $4.7 billion. There was just one problem: the technology didn't work. For years, Holmes had been misleading investors, FDA officials, and her own employees. When Carreyrou, working at the Wall Street Journal, got a tip from a former Theranos employee and started asking questions, both Carreyrou and the Journal were threatened with lawsuits. Undaunted, the newspaper ran the first of dozens of Theranos articles in late 2015. By early 2017, the company's value was zero and Holmes faced potential legal action from the government and her investors. Here is the riveting story of the biggest corporate fraud since Enron, a disturbing cautionary tale set amid the bold promises and gold-rush frenzy of Silicon Valley"--
Assigning source
  • Provided by publisher
  • Provided by publisher
Cataloging source
DLC
http://library.link/vocab/creatorName
Carreyrou, John
Dewey number
338.7/681761
Index
no index present
LC call number
HD9995.H423
LC item number
U627 2018
Literary form
non fiction
http://library.link/vocab/subjectName
  • Theranos (Firm)
  • Hematologic equipment industry
  • Fraud
  • BUSINESS & ECONOMICS / Entrepreneurship
  • BUSINESS & ECONOMICS / Finance
  • TECHNOLOGY & ENGINEERING / Biomedical
  • BUSINESS & ECONOMICS / Corporate Finance / Venture Capital
Label
Bad blood : secrets and lies in a Silicon Valley startup, John Carreyrou
Instantiates
Publication
Bibliography note
Includes bibliographical references (pages 305-324) and index
Carrier category
volume
Carrier category code
nc
Carrier MARC source
rdacarrier
Content category
text
Content type code
txt
Content type MARC source
rdacontent
Dimensions
25 cm
Edition
First edition.
Extent
x, 339 pages
Isbn
9781524731656
Isbn Type
(hardback)
Lccn
2018000263
Media category
unmediated
Media MARC source
rdamedia
Media type code
n
System control number
  • (OCoLC)1019646846
  • (OCoLC)on1019646846
  • 2697966
Label
Bad blood : secrets and lies in a Silicon Valley startup, John Carreyrou
Publication
Bibliography note
Includes bibliographical references (pages 305-324) and index
Carrier category
volume
Carrier category code
nc
Carrier MARC source
rdacarrier
Content category
text
Content type code
txt
Content type MARC source
rdacontent
Dimensions
25 cm
Edition
First edition.
Extent
x, 339 pages
Isbn
9781524731656
Isbn Type
(hardback)
Lccn
2018000263
Media category
unmediated
Media MARC source
rdamedia
Media type code
n
System control number
  • (OCoLC)1019646846
  • (OCoLC)on1019646846
  • 2697966
Processing Feedback ...